iSpecimen Inc.
ISPC
$0.42
-$0.06-13.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -96.00% | -75.10% | -53.82% | -42.70% | -4.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -96.00% | -75.10% | -53.82% | -42.70% | -4.17% |
| Cost of Revenue | -86.84% | -68.81% | -34.27% | -7.22% | 11.61% |
| Gross Profit | -108.85% | -81.31% | -68.98% | -86.81% | -20.03% |
| SG&A Expenses | 5.96% | -42.63% | -55.80% | 65.19% | -22.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.75% | -49.76% | -49.04% | 34.33% | -12.16% |
| Operating Income | -65.96% | 16.51% | 45.40% | -103.43% | 22.27% |
| Income Before Tax | -93.11% | 50.35% | 42.86% | -96.77% | 31.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -93.11% | 50.35% | 42.86% | -96.77% | 31.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -93.11% | 50.35% | 42.86% | -96.77% | 31.79% |
| EBIT | -65.96% | 16.51% | 45.40% | -103.43% | 22.27% |
| EBITDA | -68.51% | 17.06% | 46.42% | -105.57% | 24.18% |
| EPS Basic | 77.27% | 88.72% | 88.77% | 21.07% | 55.01% |
| Normalized Basic EPS | 77.28% | 88.72% | 88.77% | 21.07% | 55.01% |
| EPS Diluted | 77.27% | 88.72% | 88.77% | 21.07% | 55.01% |
| Normalized Diluted EPS | 77.28% | 88.72% | 88.77% | 21.07% | 55.01% |
| Average Basic Shares Outstanding | 749.89% | 340.37% | 408.78% | 149.29% | 51.58% |
| Average Diluted Shares Outstanding | 749.89% | 340.37% | 408.78% | 149.29% | 51.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |